Author:
Semple C. G.,Beastall G. H.,Gray C. E.,Thomson J. A.
Abstract
Abstract.
Trilostane has been used to treat 6 patients with Cushing's syndrome, 4 with an adrenal adenoma and 2 with pituitary driven disease. Three patients responded clinically and biochemically to trilostane. Although effective in some cases of Cushing's syndrome, the variability of the effect of trilostane may limit its usefulness as a therapeutic agent.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trilostane☆;Reference Module in Biomedical Sciences;2016
2. Cushing’s Syndrome;Endocrinology: Adult and Pediatric;2016
3. The Adrenal Cortex;Williams Textbook of Endocrinology;2016
4. The influence of trilostane on steroid hormone metabolism in canine adrenal glands and corpora lutea—an in vitro study;Veterinary Research Communications;2011-11-25
5. The Adrenal Cortex;Williams Textbook of Endocrinology;2011